OVERVIEW

2026 Tucson Annual Conference on Advances in Hematology & Oncology is organized by Binaytara Foundation (BTF) and will be held on Sep 12, 2026 at Tucson Marriott University Park, Tucson, Arizona, United States of America.

Description:
The 2026 Tucson Annual Conference on Advances in Hematology & Oncology is a one-day, CME-accredited educational program designed to provide clinicians with a focused update on rapidly evolving therapeutic strategies and evidence-based management across malignant hematology and solid tumors. This meeting brings together leading experts to review practice-changing clinical trial data, emerging targeted and cellular therapies, and recent updates to national and international treatment guidelines.

Through a combination of didactic presentations, case-based discussions, and interactive panel dialogue, the conference emphasizes translating new evidence into practical, real-world clinical decision-making. Participants will gain insights into optimizing treatment selection, personalizing care based on disease biology and patient-specific factors, and incorporating novel agents and updated standards into routine oncology practice.

This activity is intended to enhance clinicians' ability to critically evaluate new data and confidently integrate advances that improve patient outcomes while navigating the complexities of modern cancer care.

Learning Objectives:
At the conclusion of this activity, participants will be able to:

  1. Interpret recent clinical trial data and emerging evidence that are reshaping the management of hematologic malignancies and solid tumors.
  2. Apply updated clinical guidelines and consensus recommendations to optimize treatment selection, sequencing, and supportive care strategies.
  3. Evaluate the role of novel and targeted therapies in improving outcomes, with attention to patient selection, safety considerations, and real-world implementation.
  4. Integrate evidence-based advances into individualized treatment plans through case-based clinical reasoning aligned with contemporary standards of care.
  5. Identify practical strategies to address therapeutic complexity, toxicity management, and multidisciplinary coordination in modern oncology practice.

KEY DATES

Registrations Open
10 Jul, 2026
Registrations Open
Event Start Date
12 Sep, 2026
Event Start Date
Event End Date
12 Sep, 2026
Event End Date
Credits

6.00 AMA PRA Category 1 Credit™
The Binaytara is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara designates this live activity for a maximum of 6.00 2026 Tucson Annual Conference on Advances in Hematology & Oncology. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

6.00 ABIM MOC II
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

6.00 ACPE Pharmacy
The Binaytara is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number assigned to the activity is Participants must pass the post-test, complete course evaluation, and provide their NABP e-Profile ID number (ePID) and Date of Birth (MMDD) to Binaytara Foundation within 30-days of participating in the activity. Participants who do not complete these requirements within 30-days of participating in the 2026 Tucson Annual Conference on Advances in Hematology & Oncology activity will not be awarded the CEUs. The Binaytara may distribute a participation certificate containing information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner's e-profile in CPE Monitor®. After CPE units are processed by ACPE and NABP, pharmacists and pharmacy technicians will be able to login to a comprehensive electronic profile to access information about their completed CPE and Certificate Programs.

6.00 Nursing Contact Hours
Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.

  • 6 MOC
  • 6 AMA PRA Category 1 Credits™
  • 6 Contact Hours
  • TARGET AUDIENCE

    PhysicianPharmacistCliniciansHematologistFellowsOther Health ProfessionalsMedical OncologistsAdvanced Practice Providers

    SPECIALITIES

    HematologyOncology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationTucson Marriott University Park
    880 E 2nd St

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45